Follow us on: Facebook Twitter Linkedin

Josh Shinoff, PhD


Josh Shinoff

Josh Shinoff, Ph.D. has over 15 years of experience in evaluating, modeling, and negotiating transactions in the healthcare, pharmaceutical, medical device, and biotechnology space, leading the closure of more than 150 deals for multi-billion dollar corporations and advising on countless more. Dr. Shinoff combines expertise in a wide variety of life sciences technologies, from therapeutics to research tools, with graduate level business training that enables a broad array of investments and transactions.

Dr. Shinoff is currently the Director of Life Sciences Business Development for the Bio-Rad Laboratories Digital Biology Center (a $3B+ publicly traded company, NYSE: BIO) which is focused on next generation diagnostics and research tools, and formerly of Life Technologies Corporation (a $13B+ company traded on NASDAQ: LIFE), Applied Biosystems, Inc. (a $7B company formerly traded on NASDAQ as ABI), and Chiron Corporation (a publicly traded $10B pharmaceuticals and diagnostics company traded on NASDAQ: CHIR, now part of Novartis). Dr. Shinoff has been an invited lecturer in negotiations at the University of California at Berkeley, Haas School of Business and has led numerous corporate negotiations training sessions.

In addition, Dr. Shinoff led life sciences licensing transactions for the University of California at Berkeley where he worked with investors to launch several start-ups in the medical device, biotechnology, and pharmaceuticals industries. Dr. Shinoff also completed a fellowship in licensing and business development at the Office of Technology Licensing for the Johns Hopkins University School of Medicine. Dr. Shinoff has also consulted for the Murphy, Noell Capital Group and John Nuveen & Co., as well as been on staff for California Senator Diane Feinstein and interned for New Jersey Congressman Robert Andrews.

Dr.Shinoff holds both Ph.D. and Masters degrees from Johns Hopkins University, attended the Johns Hopkins Carey School of Business, is a graduate of the Executive Leadership Program at the Haas School of Business, is a published author, is certified by Johns Hopkins University in clinical trials conduct and management, is a Certified Licensing Professional, and is a member of the Licensing Executives Society.

Back To Team